...
search icon
mtva-img

MetaVia Inc. Share Price

MTVA
NAQ
$1.625
+$0.01
(0.62%)
1D
Industry: Biotechnology Sector: Health Care

MetaVia Inc. Analyst Forecast

MetaVia Inc. Share Price Chart

MetaVia Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.34M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
13.59K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.30
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.34 L
$20.24 H
$1.625

About MetaVia Inc., Common Stock

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd. more

Industry: BiotechnologySector: Health Care

MetaVia Inc. Stock Returns

Time FrameMTVASectorS&P500
1-Week Return1.26%-2.44%-2.28%
1-Month Return-3.01%-3.74%-2.23%
3-Month Return-82.71%-2.53%-2.29%
6-Month Return-78.97%8.72%1.33%
1-Year Return-90.24%3.85%19.22%
3-Year Return-97.53%19.83%72.98%
5-Year Return-99.99%31.03%69.03%
10-Year Return-100%119.85%229.83%

MetaVia Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue67.00K72.00K28.00K7.00K24.00K[{"date":"2020-12-31","value":93.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":38.89,"profit":true},{"date":"2023-12-31","value":9.72,"profit":true},{"date":"2024-12-31","value":33.33,"profit":true}]
Gross Profit(67.00K)(72.00K)(28.00K)(7.00K)(24.00K)[{"date":"2020-12-31","value":-6700000,"profit":false},{"date":"2021-12-31","value":-7200000,"profit":false},{"date":"2022-12-31","value":-2800000,"profit":false},{"date":"2023-12-31","value":-700000,"profit":false},{"date":"2024-12-31","value":-2400000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses29.72M15.30M19.63M15.89M28.81M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":51.48,"profit":true},{"date":"2022-12-31","value":66.05,"profit":true},{"date":"2023-12-31","value":53.46,"profit":true},{"date":"2024-12-31","value":96.95,"profit":true}]
Operating Income(29.72M)(15.30M)(19.63M)(15.89M)(28.81M)[{"date":"2020-12-31","value":-2971600000,"profit":false},{"date":"2021-12-31","value":-1529800000,"profit":false},{"date":"2022-12-31","value":-1962800000,"profit":false},{"date":"2023-12-31","value":-1588600000,"profit":false},{"date":"2024-12-31","value":-2880900000,"profit":false}]
Total Non-Operating Income/Expense77.00K28.00K3.47M3.88M2.14M[{"date":"2020-12-31","value":1.99,"profit":true},{"date":"2021-12-31","value":0.72,"profit":true},{"date":"2022-12-31","value":89.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":55.12,"profit":true}]
Pre-Tax Income(29.68M)(15.28M)(13.97M)(12.47M)(27.59M)[{"date":"2020-12-31","value":-2967800000,"profit":false},{"date":"2021-12-31","value":-1528400000,"profit":false},{"date":"2022-12-31","value":-1396700000,"profit":false},{"date":"2023-12-31","value":-1247000000,"profit":false},{"date":"2024-12-31","value":-2759200000,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(29.68M)(15.28M)(13.97M)(12.47M)(27.59M)[{"date":"2020-12-31","value":-2967800000,"profit":false},{"date":"2021-12-31","value":-1528400000,"profit":false},{"date":"2022-12-31","value":-1396700000,"profit":false},{"date":"2023-12-31","value":-1247000000,"profit":false},{"date":"2024-12-31","value":-2759200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(29.68M)(15.28M)(13.97M)(12.47M)(27.59M)[{"date":"2020-12-31","value":-2967800000,"profit":false},{"date":"2021-12-31","value":-1528400000,"profit":false},{"date":"2022-12-31","value":-1396700000,"profit":false},{"date":"2023-12-31","value":-1247000000,"profit":false},{"date":"2024-12-31","value":-2759200000,"profit":false}]
EPS (Diluted)--(1.03)(2.49)(4.23)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-103,"profit":false},{"date":"2023-12-31","value":-249,"profit":false},{"date":"2024-12-31","value":-423,"profit":false}]

MetaVia Inc. Ratios

MetaVia Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MTVA
Cash Ratio 1.69
Current Ratio 1.74

MetaVia Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MTVA
ROA (LTM) -58.41%
ROE (LTM) -168.18%

MetaVia Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MTVA
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

MetaVia Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MTVA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.81
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is MetaVia Inc. share price today?

MetaVia Inc. (MTVA) share price today is $1.625

Can Indians buy MetaVia Inc. shares?

Yes, Indians can buy shares of MetaVia Inc. (MTVA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MTVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MetaVia Inc. be purchased?

Yes, you can purchase fractional shares of MetaVia Inc. (MTVA) via the Vested app. You can start investing in MetaVia Inc. (MTVA) with a minimum investment of $1.

How to invest in MetaVia Inc. shares from India?

You can invest in shares of MetaVia Inc. (MTVA) via Vested in three simple steps:

  • Click on Sign Up or Invest in MTVA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MetaVia Inc. shares
What is MetaVia Inc. 52-week high and low stock price?

The 52-week high price of MetaVia Inc. (MTVA) is $20.24. The 52-week low price of MetaVia Inc. (MTVA) is $1.34.

What is MetaVia Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MetaVia Inc. (MTVA) is

What is MetaVia Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MetaVia Inc. (MTVA) is 0.81

What is MetaVia Inc. dividend yield?

The dividend yield of MetaVia Inc. (MTVA) is 0.00%

What is the Market Cap of MetaVia Inc.?

The market capitalization of MetaVia Inc. (MTVA) is $5.34M

What is MetaVia Inc.'s stock symbol?

The stock symbol (or ticker) of MetaVia Inc. is MTVA

How Can Investors Use MetaVia Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of MetaVia Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether MetaVia Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from MetaVia Inc. shares for Indian investors?

When investing in MetaVia Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the MetaVia Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare MetaVia Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of MetaVia Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that MetaVia Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top